Maine's drug import law puts pharma's reputation at risk, PhRMA says

10/27/2013 | FDAnews

More lawsuits could be filed against the pharmaceutical industry with the implementation of Maine's law that authorizes the direct purchase of mail-order drugs from certain foreign pharmacies. "It's our reputation that's going to be at stake, not CanaRx," said Mit Spears, executive vice president and general counsel of the Pharmaceutical Research and Manufacturers of America. The Maine law undermines the push in the U.S. for a drug track-and-trace system and could lead to similar moves in other states, Spears said.

View Full Article in:

FDAnews

Published in Brief:

SmartBrief Job Listings for Retail

Job Title Company Location
Customer Account Specialist
Strategic Market Alliance
Charlotte, NC
Hardgoods Product Manager
Independent Welding Distributors Cooperative
Indianapolis, IN
DIRECTOR OF OPERATIONS, BEVERLY HILLS
Ralph Lauren
Beverly Hills, California
Retail Channel Manager
Microsoft
Redmond, Washington
Retail Buyer/Merchandiser
Delaware North
Arizona